In this issue:
Two phase 3 dupilumab trials for AD
Re-examining the threshold for re-excision of transected dysplastic nevi
Skin cancer in nonwhite organ transplant recipients
β-HPV associated with cutaneous SCC in immunocompetent individuals
Tofacitinib for severe alopecia areata and variants
Olumacostat glasaretil for acne vulgaris
Hospitalisation for AD increases mortality
Low-dose isotretinoin for seborrhoea/seborrhoeic dermatitis
Ustekinumab in severe AD
308nm excimer light therapy for alopecia universalis
Please login below to download this issue (PDF)